Clinical Trials · NCT04616729
DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- Universitair Ziekenhuis Brussel
- Enrollment
- 30
- Start date
- Nov 2022
- Locations
- 2 sites, Belgium
- Primary endpoint
- Safety profile with regard to the risk of OHSS: assessment of change in ovarian volume